Clinical Trials Logo

Clinical Trial Summary

Background: In recent years, the changes of cognitive function in mild cognitive impairment have attracted attention. Methods/design: We will follow up at 3. The primary outcome will be the measurement of cognitive function using neuropsychological assessment scales such as MOCA, MMSE, etc... Minor variables will be included plasma biomarkers (Aβ, Tau, GFAP, etc.), multimodal brain electrophysiology (P300, VP300, heart rate variability, etc.), and neuroimaging indicators (NODDI).


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT05821400
Study type Observational
Source Fujian Medical University Union Hospital
Contact Xiaodong Pan, Doctor
Phone 86218341
Email pxd77316@163.com
Status Recruiting
Phase
Start date March 1, 2023
Completion date June 30, 2024